Showing results (401-410 of 416) with videos related to
Sort By:
Pageof 42
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.ACS Medicinal Chemistry Letters|March 21, 2019
Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481Kenneth M Boy, Jason M Guernon, Dmitry S Zuev, et al.Journal of Medicinal Chemistry|September 8, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic TherapyAndrew K Dilger, Kumar B Pabbisetty, James R Corte, et al.Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.Plant Phenomics (Washington, D.C.)|November 15, 2021
Global Wheat Head Detection 2021: An Improved Dataset for Benchmarking Wheat Head Detection MethodsEtienne David, Mario Serouart, Daniel Smith, et al.Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaTarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.Movement Ecology|April 23, 2024
From little things big things grow: enhancement of an acoustic telemetry network to monitor broad-scale movements of marine species along Australia's east coastAdam Barnett, Fabrice R A Jaine, Stacy L Bierwagen, et al.Journal of Medicinal Chemistry|March 21, 2019
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)Scott H Watterson, Qingjie Liu, Myra Beaudoin Bertrand, et al.Journal of Medicinal Chemistry|October 28, 2021
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic DiseasesPeter T W Cheng, Robert F Kaltenbach, Hao Zhang, et al.Pageof 42